NICE (UK) revised timeline to appraise the clinical and cost effectiveness of icosapent ethyl | AMRN Message Board Posts


Amarin Corporation plc

  AMRN website

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  8564 of 8608  at  6/21/2021 7:11:42 PM  by

lettruthringout


 In response to msg 8416 by  lettruthringout
view thread

Re: NICE (UK) revised timeline to appraise the clinical and cost effectiveness of icosapent ethyl

 
Quote:
Committee meeting 13 October 2021. Results of evaluation process scheduled for publication 5 January 2022.


Timeline slips: Committee meeting now January 11, 2022; results now scheduled for publication March  23, 2022.
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2  
   Views: 0 [1]
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
8566 Re: NICE (UK) revised timeline to appraise the clinical and cost effectiveness of icosapent ethyl ex_hacker202 0 6/22/2021 11:49:38 AM


Financial Market Data provided by
.
Loading...